|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 276 out of 276 for Cxcl5

<< First    < Previous  |  Next >    Last >>
0.022s
Type Details Score
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2010
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome U74 Array Platform (A, B, C v2).
Publication      
First Author: Mouse Genome Informatics (MGI) and The National Center for Biotechnology Information (NCBI)
Year: 2010
Journal: Database Download
Title: Consensus CDS project
Publication      
First Author: Mouse Genome Informatics
Year: 2010
Journal: Database Release
Title: Protein Ontology Association Load.
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and loading genome assembly coordinates from NCBI annotations
Publication      
First Author: MGI Genome Annotation Group and UniGene Staff
Year: 2015
Journal: Database Download
Title: MGI-UniGene Interconnection Effort
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform
Publication      
First Author: Allen Institute for Brain Science
Year: 2004
Journal: Allen Institute
Title: Allen Brain Atlas: mouse riboprobes
Publication      
First Author: The Jackson Laboratory Mouse Radiation Hybrid Database
Year: 2004
Journal: Database Release
Title: Mouse T31 Radiation Hybrid Data Load
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Mouse Synonym Curation
Publication
First Author: Herjan T
Year: 2013
Journal: J Immunol
Title: HuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization.
Volume: 191
Issue: 2
Pages: 640-9
Publication
First Author: Shimoura N
Year: 2018
Journal: J Invest Dermatol
Title: Exacerbation and Prolongation of Psoriasiform Inflammation in Diabetic Obese Mice: A Synergistic Role of CXCL5 and Endoplasmic Reticulum Stress.
Volume: 138
Issue: 4
Pages: 854-863
Allele
Name: C-X-C motif chemokine ligand 5; endonuclease-mediated mutation 1, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
Publication
First Author: Chen Y
Year: 2021
Journal: Cancer Cell
Title: Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer.
Volume: 39
Issue: 4
Pages: 548-565.e6
Publication
First Author: Toh B
Year: 2011
Journal: PLoS Biol
Title: Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor.
Volume: 9
Issue: 9
Pages: e1001162
Publication
First Author: Mathur AN
Year: 2019
Journal: Immunity
Title: Treg-Cell Control of a CXCL5-IL-17 Inflammatory Axis Promotes Hair-Follicle-Stem-Cell Differentiation During Skin-Barrier Repair.
Volume: 50
Issue: 3
Pages: 655-667.e4
Publication
First Author: Maji S
Year: 2023
Journal: Proc Natl Acad Sci U S A
Title: MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.
Volume: 120
Issue: 45
Pages: e2307094120
Publication
First Author: Novitskiy SV
Year: 2011
Journal: Cancer Discov
Title: TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms.
Volume: 1
Issue: 5
Pages: 430-41
Publication
First Author: Gonzalez C
Year: 2023
Journal: Commun Biol
Title: TLR5 agonists enhance anti-tumor immunity and overcome resistance to immune checkpoint therapy.
Volume: 6
Issue: 1
Pages: 31
Publication
First Author: Liang SC
Year: 2007
Journal: J Immunol
Title: An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment.
Volume: 179
Issue: 11
Pages: 7791-9
Publication
First Author: Riedel JH
Year: 2016
Journal: J Am Soc Nephrol
Title: IL-17F Promotes Tissue Injury in Autoimmune Kidney Diseases.
Volume: 27
Issue: 12
Pages: 3666-3677
Publication
First Author: Yamamoto K
Year: 2012
Journal: J Immunol
Title: Type I alveolar epithelial cells mount innate immune responses during pneumococcal pneumonia.
Volume: 189
Issue: 5
Pages: 2450-9
Publication
First Author: Yamamoto K
Year: 2014
Journal: Am J Respir Cell Mol Biol
Title: Roles of lung epithelium in neutrophil recruitment during pneumococcal pneumonia.
Volume: 50
Issue: 2
Pages: 253-62
Publication
First Author: Fogli LK
Year: 2013
Journal: J Immunol
Title: T cell-derived IL-17 mediates epithelial changes in the airway and drives pulmonary neutrophilia.
Volume: 191
Issue: 6
Pages: 3100-11
Publication
First Author: Ince LM
Year: 2019
Journal: FASEB J
Title: Circadian variation in pulmonary inflammatory responses is independent of rhythmic glucocorticoid signaling in airway epithelial cells.
Volume: 33
Issue: 1
Pages: 126-139
Publication
First Author: Tester AM
Year: 2007
Journal: PLoS One
Title: LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity.
Volume: 2
Issue: 3
Pages: e312
Publication
First Author: Griffin GK
Year: 2012
Journal: J Immunol
Title: IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation.
Volume: 188
Issue: 12
Pages: 6287-99
Publication
First Author: Lee R
Year: 2022
Journal: Cancer Discov
Title: Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer.
Volume: 12
Issue: 7
Pages: 1702-1717
Publication
First Author: Wang G
Year: 2016
Journal: Cancer Discov
Title: Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.
Volume: 6
Issue: 1
Pages: 80-95
Publication
First Author: Ma S
Year: 2014
Journal: Cancer Res
Title: IL-17A produced by γδ T cells promotes tumor growth in hepatocellular carcinoma.
Volume: 74
Issue: 7
Pages: 1969-82
Publication
First Author: Foronjy RF
Year: 2016
Journal: Am J Physiol Lung Cell Mol Physiol
Title: TLR9 expression is required for the development of cigarette smoke-induced emphysema in mice.
Volume: 311
Issue: 1
Pages: L154-66
Publication
First Author: Sun L
Year: 2020
Journal: J Immunol
Title: IL-10 Dampens an IL-17-Mediated Periodontitis-Associated Inflammatory Network.
Volume: 204
Issue: 8
Pages: 2177-2191
Publication  
First Author: Jones SS
Year: 2022
Journal: Front Immunol
Title: Lyl1-deficiency promotes inflammatory responses and increases mycobacterial burden in response to Mycobacterium tuberculosis infection in mice.
Volume: 13
Pages: 948047
Publication  
First Author: Kubota A
Year: 2019
Journal: J Mol Cell Cardiol
Title: Matrix metalloproteinase-12 produced by Ly6Clow macrophages prolongs the survival after myocardial infarction by preventing neutrophil influx.
Volume: 131
Pages: 41-52
Publication
First Author: Li X
Year: 2012
Journal: Mol Cancer Res
Title: Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
Volume: 10
Issue: 4
Pages: 494-503
Publication
First Author: Wang Q
Year: 2020
Journal: Cancer Res
Title: ARC Is a Critical Protector against Inflammatory Bowel Disease (IBD) and IBD-Associated Colorectal Tumorigenesis.
Volume: 80
Issue: 19
Pages: 4158-4171
Publication
First Author: Chen W
Year: 2017
Journal: J Immunol
Title: Steroid Receptor Coactivator 3 Contributes to Host Defense against Enteric Bacteria by Recruiting Neutrophils via Upregulation of CXCL2 Expression.
Volume: 198
Issue: 4
Pages: 1606-1615
Publication
First Author: Jung K
Year: 2017
Journal: J Clin Invest
Title: Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.
Volume: 127
Issue: 8
Pages: 3039-3051
Publication
First Author: Matoba H
Year: 2020
Journal: Am J Pathol
Title: Cecal Tumorigenesis in Aryl Hydrocarbon Receptor-Deficient Mice Depends on Cecum-Specific Mitogen-Activated Protein Kinase Pathway Activation and Inflammation.
Volume: 190
Issue: 2
Pages: 453-468
Publication
First Author: Martinu T
Year: 2019
Journal: Transplantation
Title: IL-17A Contributes to Lung Fibrosis in a Model of Chronic Pulmonary Graft-versus-host Disease.
Volume: 103
Issue: 11
Pages: 2264-2274
Publication
First Author: Chen J
Year: 2015
Journal: Exp Hematol
Title: Immune-mediated bone marrow failure in C57BL/6 mice.
Volume: 43
Issue: 4
Pages: 256-67
Publication
First Author: Jin L
Year: 2017
Journal: PLoS Pathog
Title: Diminished neutrophil extracellular trap (NET) formation is a novel innate immune deficiency induced by acute ethanol exposure in polymicrobial sepsis, which can be rescued by CXCL1.
Volume: 13
Issue: 9
Pages: e1006637
Publication
First Author: Zuk A
Year: 2014
Journal: Am J Physiol Renal Physiol
Title: CXCRâ‚„antagonism as a therapeutic approach to prevent acute kidney injury.
Volume: 307
Issue: 7
Pages: F783-97
Publication
First Author: Lin D
Year: 2015
Journal: Eur J Immunol
Title: Secreted IL-1α promotes T-cell activation and expansion of CD11b(+) Gr1(+) cells in carbon tetrachloride-induced liver injury in mice.
Volume: 45
Issue: 7
Pages: 2084-98
Publication
First Author: Vanderstocken G
Year: 2018
Journal: Am J Respir Cell Mol Biol
Title: Identification of Drug Candidates to Suppress Cigarette Smoke-induced Inflammation via Connectivity Map Analyses.
Volume: 58
Issue: 6
Pages: 727-735
Publication
First Author: Kawagoe Y
Year: 2020
Journal: Aging Cell
Title: CXCL5-CXCR2 signaling is a senescence-associated secretory phenotype in preimplantation embryos.
Volume: 19
Issue: 10
Pages: e13240
Publication
First Author: Jia H
Year: 2016
Journal: J Immunol
Title: Pulmonary Epithelial TLR4 Activation Leads to Lung Injury in Neonatal Necrotizing Enterocolitis.
Volume: 197
Issue: 3
Pages: 859-71
Publication
First Author: Chao T
Year: 2016
Journal: Cancer Immunol Res
Title: CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.
Volume: 4
Issue: 11
Pages: 968-982
Publication
First Author: Cox SL
Year: 2023
Journal: FASEB J
Title: Circadian disruption in lung fibroblasts enhances NF-κB activity to exacerbate neutrophil recruitment.
Volume: 37
Issue: 2
Pages: e22753
Publication
First Author: Fu W
Year: 2005
Journal: Cytokine
Title: Cloning and characterization of mouse homolog of the CXC chemokine receptor CXCR1.
Volume: 31
Issue: 1
Pages: 9-17
Publication
First Author: Cerretti DP
Year: 1993
Journal: Mol Immunol
Title: Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2.
Volume: 30
Issue: 4
Pages: 359-67
Publication
First Author: Lee J
Year: 1992
Journal: J Biol Chem
Title: Characterization of two high affinity human interleukin-8 receptors.
Volume: 267
Issue: 23
Pages: 16283-7
Publication
First Author: Ludwig A
Year: 2000
Journal: J Immunol
Title: Identification of distinct surface-expressed and intracellular CXC-chemokine receptor 2 glycoforms in neutrophils: N-glycosylation is essential for maintenance of receptor surface expression.
Volume: 165
Issue: 2
Pages: 1044-52
Publication
First Author: Dunstan CA
Year: 1996
Journal: J Biol Chem
Title: Identification of two rat genes orthologous to the human interleukin-8 receptors.
Volume: 271
Issue: 51
Pages: 32770-6
Publication
First Author: Doroshenko T
Year: 2002
Journal: Blood
Title: Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2.
Volume: 100
Issue: 7
Pages: 2668-71
Publication
First Author: Chuntharapai A
Year: 1994
Journal: J Immunol
Title: Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes.
Volume: 153
Issue: 12
Pages: 5682-8
Publication
First Author: Bizzarri C
Year: 2006
Journal: Pharmacol Ther
Title: ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
Volume: 112
Issue: 1
Pages: 139-49
Publication
First Author: Heidemann J
Year: 2003
Journal: J Biol Chem
Title: Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.
Volume: 278
Issue: 10
Pages: 8508-15
Publication  
First Author: Konrad FM
Year: 2012
Journal: Mediators Inflamm
Title: CXCR2 in acute lung injury.
Volume: 2012
Pages: 740987
Protein Domain
Type: Family
Description: Chemokines (chemotactic cytokines) are a family of chemoattractant molecules. They attract leukocytes to areas of inflammation and lesions, and play a key role in leukocyte activation. Originally defined as host defense proteins, chemokines are now known to play a much broader biological role []. They have a wide range of effects in many different cell types beyond the immune system, including, for example, various cells of the central nervous system [], and endothelial cells, where they may act as either angiogenic or angiostatic factors [].The chemokine family is divided into four classes based on the number and spacing of their conserved cysteines: 2 Cys residues may be adjacent (the CC family); separated by an intervening residue (the CXC family); have only one of the first two Cys residues (C chemokines); or contain both cysteines, separated by three intervening residues (CX3C chemokines).Chemokines exert their effects by binding to rhodopsin-like G protein-coupled receptors on the surface of cells. Following interaction with their specific chemokine ligands, chemokine receptors trigger a flux in intracellular calcium ions, which cause a cellular response, including the onset of chemotaxis. There are over fifty distinct chemokines and least 18 human chemokine receptors []. Although the receptors bind only a single class of chemokines, they often bind several members of the same class with high affinity. Chemokine receptors are preferentially expressed on important functional subsets of dendritic cells, monocytes and lymphocytes, including Langerhans cells and T helper cells [, ]. Chemokines and their receptors can also be subclassified into homeostatic leukocyte homing molecules (CXCR4, CXCR5, CCR7, CCR9) versus inflammatory/inducible molecules (CXCR1, CXCR2, CXCR3, CCR1-6, CX3CR1).The CXC chemokine receptors are a subfamily of chemokine receptors that specifically bind and respond to cytokines of the CXC chemokine family. There are currently seven known CXC chemokine receptors in mammals, CXCR1 through to CXCR7.CXCR1 and CXCR2, also known as interleukin 8 receptor alpha and beta, respectively [], are closely-related receptors. They act as specific receptors for the CXCL8 and CXCL6 chemokines, which have a glutamate-leucine-arginine (ELR) motif in their N-terminal domains []. CXCR2 also binds additional ELR motif-containing CXC chemokines (such as CXCL1, CXCL2, CXCL3, CXCL5 and CXCL7) with high affinity [].CXCR1 and CXCR2 are expressed on all granulocytes, monocytes, and mast cells and on some CD8+ T-cells and CD56+ natural killer (NK) cells []. Equal amounts of CXCR1 and CXCR2 are present on neutrophils [, , , , ], but it appears that monocytes and positive lymphocytes express more CXCR2 than CXCR1 [].This entry represents both CXCR1 and CXCR2.
Protein Domain
Type: Family
Description: Chemokines (chemotactic cytokines) are a family of chemoattractant molecules. They attract leukocytes to areas of inflammation and lesions, and play a key role in leukocyte activation. Originally defined as host defense proteins, chemokines are now known to play a much broader biological role []. They have a wide range of effects in many different cell types beyond the immune system, including, for example, various cells of the central nervous system [], and endothelial cells, where they may act as either angiogenic or angiostatic factors [].The chemokine family is divided into four classes based on the number and spacing of their conserved cysteines: 2 Cys residues may be adjacent (the CC family); separated by an intervening residue (the CXC family); have only one of the first two Cys residues (C chemokines); or contain both cysteines, separated by three intervening residues (CX3C chemokines).Chemokines exert their effects by binding to rhodopsin-like G protein-coupled receptors on the surface of cells. Following interaction with their specific chemokine ligands, chemokine receptors trigger a flux in intracellular calcium ions, which cause a cellular response, including the onset of chemotaxis. There are over fifty distinct chemokines and least 18 human chemokine receptors []. Although the receptors bind only a single class of chemokines, they often bind several members of the same class with high affinity. Chemokine receptors are preferentially expressed on important functional subsets of dendritic cells, monocytes and lymphocytes, including Langerhans cells and T helper cells [, ]. Chemokines and their receptors can also be subclassified into homeostatic leukocyte homing molecules (CXCR4, CXCR5, CCR7, CCR9) versus inflammatory/inducible molecules (CXCR1, CXCR2, CXCR3, CCR1-6, CX3CR1).The CXC chemokine receptors are a subfamily of chemokine receptors that specifically bind and respond to cytokines of the CXC chemokine family. There are currently seven known CXC chemokine receptors in mammals, CXCR1 through to CXCR7.CXCR1 and CXCR2, also known as interleukin 8 receptor alpha and beta, respectively [], are closely-relatedreceptors. They act as specific receptors for the CXCL8 and CXCL6 chemokines, which have a glutamate-leucine-arginine (ELR) motif in their N-terminal domains []. CXCR2 also binds additional ELR motif-containing CXC chemokines (such as CXCL1, CXCL2, CXCL3, CXCL5 and CXCL7) with high affinity [].CXCR1 and CXCR2 are expressed on all granulocytes, monocytes, and mast cells and on some CD8+ T-cells and CD56+ natural killer (NK) cells []. Equal amounts of CXCR1 and CXCR2 are present on neutrophils [, , , , ], but it appears that monocytes and positive lymphocytes express more CXCR2 than CXCR1 [].This entry represents CXCR2. The angiogenic effects of CXCL8 in intestinal microvascular endothelial cells are mediated by this receptor []. It has been suggested that the receptor may be a potential theraputic target in acute lung injury [].
Protein Domain
Type: Family
Description: Chemokines (chemotactic cytokines) are a family of chemoattractant molecules. They attract leukocytes to areas of inflammation and lesions, and play a key role in leukocyte activation. Originally defined as host defense proteins, chemokines are now known to play a much broader biological role []. They have a wide range of effects in many different cell types beyond the immune system, including, for example, various cells of the central nervous system [], and endothelial cells, where they may act as either angiogenic or angiostatic factors [].The chemokine family is divided into four classes based on the number and spacing of their conserved cysteines: 2 Cys residues may be adjacent (the CC family); separated by an intervening residue (the CXC family); have only one of the first two Cys residues (C chemokines); or contain both cysteines, separated by three intervening residues (CX3C chemokines).Chemokines exert their effects by binding to rhodopsin-like G protein-coupled receptors on the surface of cells. Following interaction with their specific chemokine ligands, chemokine receptors trigger a flux in intracellular calcium ions, which cause a cellular response, including the onset of chemotaxis. There are over fifty distinct chemokines and least 18 human chemokine receptors []. Although the receptors bind only a single class of chemokines, they often bind several members of the same class with high affinity. Chemokine receptors are preferentially expressed on important functional subsets of dendritic cells, monocytes and lymphocytes, including Langerhans cells and T helper cells [, ]. Chemokines and their receptors can also be subclassified into homeostatic leukocyte homing molecules (CXCR4, CXCR5, CCR7, CCR9) versus inflammatory/inducible molecules (CXCR1, CXCR2, CXCR3, CCR1-6, CX3CR1).The CXC chemokine receptors are a subfamily of chemokine receptors that specifically bind and respond to cytokines of the CXC chemokine family. There are currently seven known CXC chemokine receptors in mammals, CXCR1 through to CXCR7.CXCR1 and CXCR2, also known as interleukin 8 receptor alpha and beta, respectively [], are closely-related receptors. They act as specific receptors for the CXCL8 and CXCL6 chemokines, which have a glutamate-leucine-arginine (ELR) motif in their N-terminal domains []. CXCR2 also binds additional ELR motif-containing CXC chemokines (such as CXCL1, CXCL2, CXCL3, CXCL5 and CXCL7) with high affinity [].CXCR1 and CXCR2 are expressed on all granulocytes, monocytes, and mast cells and on some CD8+ T-cells and CD56+ natural killer (NK) cells []. Equal amounts of CXCR1 and CXCR2 are present on neutrophils [, , , , ], but it appears that monocytes and positive lymphocytes express more CXCR2 than CXCR1 [].This entry represents CXCR1
Publication  
First Author: Götz AA
Year: 2011
Journal: Part Fibre Toxicol
Title: Carbon-nanoparticle-triggered acute lung inflammation and its resolution are not altered in PPARγ-defective (P465L) mice.
Volume: 8
Pages: 28
Publication
First Author: Li X
Year: 2020
Journal: Theranostics
Title: A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis.
Volume: 10
Issue: 13
Pages: 5687-5703
Publication
First Author: Stachon P
Year: 2014
Journal: Arterioscler Thromb Vasc Biol
Title: P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
Volume: 34
Issue: 10
Pages: 2237-45
Publication
First Author: Niazi MK
Year: 2015
Journal: Dis Model Mech
Title: Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice.
Volume: 8
Issue: 9
Pages: 1141-53
Publication
First Author: Suzuki K
Year: 2019
Journal: Cell Mol Gastroenterol Hepatol
Title: Deficiency of Stomach-Type Claudin-18 in Mice Induces Gastric Tumor Formation Independent of H pylori Infection.
Volume: 8
Issue: 1
Pages: 119-142
Protein
Organism: Mus musculus/domesticus
Length: 359  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 351  
Fragment?: false
Publication
First Author: Ma Q
Year: 1998
Journal: Proc Natl Acad Sci U S A
Title: Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.
Volume: 95
Issue: 16
Pages: 9448-53
Publication
First Author: Horuk R
Year: 2001
Journal: Cytokine Growth Factor Rev
Title: Chemokine receptors.
Volume: 12
Issue: 4
Pages: 313-35
Publication
First Author: Charbonnier AS
Year: 1999
Journal: J Exp Med
Title: Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells.
Volume: 190
Issue: 12
Pages: 1755-68
Publication
First Author: Sallusto F
Year: 1998
Journal: J Exp Med
Title: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.
Volume: 187
Issue: 6
Pages: 875-83
Publication
First Author: Strieter RM
Year: 1995
Journal: J Biol Chem
Title: The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.
Volume: 270
Issue: 45
Pages: 27348-57
Publication
First Author: Zlotnik A
Year: 2000
Journal: Immunity
Title: Chemokines: a new classification system and their role in immunity.
Volume: 12
Issue: 2
Pages: 121-7